Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Hoch

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Schmerz (Berlin, Germany)|September 4, 2019
[Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling]Winfried Häuser, Eva Hoch, Frank Petzke, et al.
Frontiers in Psychiatry|February 24, 2025
DAILY - A personalized circadian <i>Zeitgeber</i> therapy as an adjunctive treatment for alcohol use disorder patients: results of a pilot trialNaomi Springer, Lisa Echtler, Paul Volkmann, et al.
Burns : Journal of the International Society for Burn Injuries|December 3, 2014
Adipose-derived stem cells cultivated on electrospun l-lactide/glycolide copolymer fleece and gelatin hydrogels under flow conditions - aiming physiological reality in hypodermis tissue engineeringAlfred Gugerell, Anne Neumann, Johanna Kober, et al.
Die Rehabilitation|January 24, 2018
[Health Care Organization - The New German S3-Guideline on Alcohol-Related Disorders and its Relevance for Health Care]Arthur Günthner, Volker Weissinger, Heribert Fleischmann, et al.
European Addiction Research|August 14, 2017
A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European UnionGianLuca Quaglio, Arnt Schellekens, Matthijs Blankers, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
Journal of Cannabis Research|April 29, 2026
Through the haze: a multinational cross-sectional comparison of cannabis risk knowledge gaps among young adultsAnne Maiwald, Elena Gomes de Matos, Sally Olderbak, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2020
Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatmentFlorian J Raabe, Elias Wagner, Judith Weiser, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2019
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic reviewEva Hoch, Dominik Niemann, Rupert von Keller, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2019
Correction to: How effective and safe is medical cannabis as a treatment of mental disorders? A systematic reviewEva Hoch, Dominik Niemann, Rupert von Keller, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Schmerz (Berlin, Germany)|September 4, 2019
[Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling]Winfried Häuser, Eva Hoch, Frank Petzke, et al.
Frontiers in Psychiatry|February 24, 2025
DAILY - A personalized circadian <i>Zeitgeber</i> therapy as an adjunctive treatment for alcohol use disorder patients: results of a pilot trialNaomi Springer, Lisa Echtler, Paul Volkmann, et al.
Burns : Journal of the International Society for Burn Injuries|December 3, 2014
Adipose-derived stem cells cultivated on electrospun l-lactide/glycolide copolymer fleece and gelatin hydrogels under flow conditions - aiming physiological reality in hypodermis tissue engineeringAlfred Gugerell, Anne Neumann, Johanna Kober, et al.
Die Rehabilitation|January 24, 2018
[Health Care Organization - The New German S3-Guideline on Alcohol-Related Disorders and its Relevance for Health Care]Arthur Günthner, Volker Weissinger, Heribert Fleischmann, et al.
European Addiction Research|August 14, 2017
A Brief Outline of the Use of New Technologies for Treating Substance Use Disorders in the European UnionGianLuca Quaglio, Arnt Schellekens, Matthijs Blankers, et al.
Psychological Medicine|February 4, 2021
Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative reviewRachel Lees, Lindsey A Hines, Deepak Cyril D'Souza, et al.
Journal of Cannabis Research|April 29, 2026
Through the haze: a multinational cross-sectional comparison of cannabis risk knowledge gaps among young adultsAnne Maiwald, Elena Gomes de Matos, Sally Olderbak, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2020
Classical blood biomarkers identify patients with higher risk for relapse 6 months after alcohol withdrawal treatmentFlorian J Raabe, Elias Wagner, Judith Weiser, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 2, 2019
How effective and safe is medical cannabis as a treatment of mental disorders? A systematic reviewEva Hoch, Dominik Niemann, Rupert von Keller, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2019
Correction to: How effective and safe is medical cannabis as a treatment of mental disorders? A systematic reviewEva Hoch, Dominik Niemann, Rupert von Keller, et al.
Pageof 7